RetinAI's Precision Medicine initiative focuses on developing Digital Precision Medicine (DPM) solutions to deliver personalized, comprehensive care to patients. By integrating genotype and phenotype data, RetinAI aims to support complex clinical decisions, enhance patient engagement, and identify optimal treatment regimens for specific patient populations. Their RetinAI Discovery® platform leverages advanced AI technology for data management and enrichment, facilitating the distribution of DPM solutions at scale through a secure and certified platform. This approach addresses the challenges of diverse data sources and formats, enabling healthcare providers to offer tailored treatments and improve patient outcomes.